Lv1
90 积分 2025-04-28 加入
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer
3个月前
已完结
Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer
3个月前
已完结
Perioperative Nivolumab and Chemotherapy in Stage III Non–Small-Cell Lung Cancer
3个月前
已完结
Outcomes after neoadjuvant therapy with/without immunotherapy followed by pneumonectomy in non-small cell lung cancer patients
3个月前
已完结
Influence of Cycles of Neoadjuvant Chemoimmunotherapy on Treatment Response in Stage IIIA–N2IIIB Non-small Cell Lung Cancer: Experience from a Large-Volume Center
3个月前
已完结
OA13.03 Perioperative Durvalumab for Resectable NSCLC (R-NSCLC): Updated Outcomes from the Phase 3 AEGEAN Trial
4个月前
已完结
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial
4个月前
已完结
A Single-Arm, Open-Label, Phase Ib Clinical Study Evaluating the Efficacy and Safety of Durvalumab in Combination with Albumin-Bound Paclitaxel and Carboplatin as Neoadjuvant Therapy for Resectable Stage III Non-Small Cell Lung Cancer
6个月前
已完结
A Single-Arm, Open-Label, Phase Ib Clinical Study Evaluating the Efficacy and Safety of Durvalumab in Combination with Albumin-Bound Paclitaxel and Carboplatin as Neoadjuvant Therapy for Resectable Stage III Non-Small Cell Lung Cancer
6个月前
已完结
SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non–Small-Cell Lung Cancer—A Multicenter Single-Arm Phase II Trial
6个月前
已完结
皖公网安备34019202002308
